The impact of co-morbidity on life expectancy among men with localized prostate cancer
- PMID: 8648773
The impact of co-morbidity on life expectancy among men with localized prostate cancer
Abstract
Purpose: We evaluated 3 indexes used to assess patient co-morbidities to determine whether they could predict mortality among men with clinically localized prostate cancer.
Materials and methods: We measured the impact of co-morbidity classifications on all cause mortality using a parametric proportional hazards model based on a retrospective cohort analysis.
Results: Each index tested is a highly significant predictor of mortality for patients dying of nonprostate cancer related causes after adjusting for age and Gleason score.
Conclusions: Each co-morbidity index provides significant, independent predictive information concerning patient mortality beyond that provided by age, Gleason score and clinical stage alone.
Comment in
-
Prostate cancer--the added factors.J Urol. 1996 Jul;156(1):144-5. doi: 10.1016/s0022-5347(01)65968-8. J Urol. 1996. PMID: 8648776 No abstract available.
-
Re: The impact of co-morbidity on life expectancy among men with localized prostate cancer.J Urol. 1997 Mar;157(3):964-5. doi: 10.1016/s0022-5347(01)65114-0. J Urol. 1997. PMID: 9072623 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical